Harvey Investment Company’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4M Buy
115,960
+14,820
+15% +$3.18M 2.66% 14
2026
Q1
$22.4M Buy
101,140
+8,545
+9% +$2.09M 2.46% 16
2025
Q4
$23.5M Sell
92,595
-510
-0.5% -$128K 2.5% 17
2025
Q3
$23M Buy
93,105
+13,580
+17% +$3.25M 2.46% 16
2025
Q2
$19.1M Buy
79,525
+12,865
+19% +$3M 2.1% 20
2025
Q1
$15.1M Buy
66,660
+10,300
+18% +$2.27M 1.68% 22
2024
Q4
$11.6M Buy
+56,360
New +$12.4M 1.34% 27

Other funds holding STE

Harvey Investment Company's STE Position: Q2 2026 in Review

Harvey Investment Company increased its Steris (STE) stake by 15% in Q2 2026, buying an estimated $3.18M and bringing the position to 115,960 shares worth $24.4M. The position accounts for 2.66% of the portfolio, ranked #14.

Harvey Investment Company first reported a position in STE in Q4 2024 and has held it in 7 quarters since. 188 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Harvey Investment Company held 115,960 shares of Steris worth $24.4M as of Q2 2026.
  • Harvey Investment Company bought 14,820 Steris shares in Q2 2026, an estimated $3.18M.
  • Steris made up 2.66% of Harvey Investment Company's portfolio in Q2 2026, its #14 holding.
  • Harvey Investment Company first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • 188 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Harvey Investment Company's 13F filing for Q2 2026, filed 22 Jul 2026.